News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,631 Results
Type
Article (8056)
Company Profile (140)
Press Release (476434)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166830)
Career Advice (304)
Deals (25752)
Drug Delivery (7)
Drug Development (52924)
Employer Resources (14)
FDA (9768)
Job Trends (8582)
News (238341)
Policy (17918)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33170)
ALS (104)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (262)
Approvals (10377)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6968)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (506)
Cancer (3627)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (173)
Celiac Disease (1)
Cell therapy (477)
Cervical cancer (34)
Clinical research (47877)
Collaboration (1238)
Commercialization (3)
Compensation (1445)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (737)
Cystic fibrosis (85)
Data (5613)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4178)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73629)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87626)
Executive appointments (697)
FDA (12373)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (909)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (298)
Government (943)
Grass and pollen (2)
Guidances (281)
Healthcare (9328)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (155)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12390)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (2)
Kidney cancer (16)
Layoffs (60)
Legal (5200)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (505)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (527)
Marketing (8)
MASH (123)
Medical device (8696)
Medtech (8836)
Mergers & acquisitions (14387)
Metabolic disorders (709)
mRNA (54)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1819)
NextGen: Class of 2026 (3165)
Non-profit (842)
Obesity (223)
Opinion (12)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (502)
Peanut (31)
People (41231)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15460)
Phase 2 (21394)
Phase 3 (14402)
Pipeline (7172)
Policy (18)
Postmarket research (1570)
Preclinical (6537)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3019)
Recruiting (6)
Regulatory (14801)
Reports (19)
Research institute (582)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2023)
Stomach cancer (3)
Supply chain (50)
Vaccines (317)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (70)
Last 7 days (479)
Last 30 days (1649)
Last 365 days (19124)
2026 (11969)
2025 (19263)
2024 (23025)
2023 (26565)
2022 (34627)
2021 (37205)
2020 (33505)
2019 (23299)
2018 (17528)
2017 (18774)
2016 (17931)
2015 (24273)
2014 (21688)
2013 (18137)
2012 (20223)
2011 (20447)
2010 (20338)
Location
Africa (228)
Alabama (72)
Alaska (2)
Arizona (300)
Arkansas (11)
Asia (17900)
Australia (2105)
California (11885)
Canada (3118)
China (519)
Colorado (479)
Connecticut (406)
Delaware (207)
Europe (24651)
Florida (1774)
Georgia (373)
Hawaii (3)
Idaho (46)
Illinois (694)
India (48)
Indiana (316)
Iowa (14)
Japan (399)
Kansas (100)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1190)
Massachusetts (7813)
Michigan (307)
Minnesota (558)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2604)
New Mexico (12)
New York (2802)
North Carolina (1264)
North Dakota (4)
Northern California (5941)
Ohio (276)
Oklahoma (14)
Oregon (16)
Pennsylvania (2242)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4942)
Tennessee (119)
Texas (1915)
United States (38595)
Utah (357)
Vermont (1)
Virginia (152)
Washington D.C. (39)
Washington State (919)
West Virginia (1)
Wisconsin (73)
484,631 Results for "resmed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026
August 6, 2026
·
20 min read
Press Releases
Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026
June 30, 2026
·
1 min read
Press Releases
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
June 2, 2026
·
3 min read
Press Releases
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
April 30, 2026
·
19 min read
Press Releases
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
May 20, 2026
·
1 min read
Press Releases
Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
April 30, 2026
·
3 min read
Press Releases
Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
January 30, 2026
·
18 min read
Press Releases
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
February 24, 2026
·
2 min read
Press Releases
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
January 9, 2026
·
1 min read
Press Releases
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
October 31, 2025
·
15 min read
1 of 48,464
Next
